Toll-like receptor 4 (TLR4) and MD-2 recognize lipid A, the active moiety of microbial lipopolysaccharide (LPS). Little is known about mechanisms for LPS recognition by TLR4/MD-2. We here showed, by using in vitro transfectants, ligand-induced TLR4-oligomerization, which required both membrane CD14 and MD-2. We previously reported that lipid IVa, a lipid A precursor, is agonistic on mouse TLR4/MD-2 but antagonistic on human TLR4/MD-2 and chimeric mouse TLR4/human MD-2. Lipid IVa triggered oligomerization of mouse TLR4/MD-2 but not human TLR4/MD-2 or chimeric mouse TLR4/human MD-2. Further, lipid IVa inhibited lipid A-dependent oligomerization of chimeric mouse TLR4/human MD-2. These results demonstrate that ligand-induced TLR4-oligomerization is directly linked with TLR4-signaling and suggest that MD-2 has an important role in regulating TLR4-oligomerization.
Janeway Jr CA , Medzhitov R.Innate immune recognition. Annu Rev Immunol2002; 20: 197—216.
2.
Takeda K., Kaisho T., Akira S.Toll-like receptors. Annu Rev Immunol2003 ; 21: 335—376.
3.
Medzhitov R. , Preston-Hurlburt P., Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity . Nature1997; 388: 394—397.
4.
Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
5.
Qureshi ST, Lariviere L., Leveque G. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med1999; 189: 615—625.
6.
Hoshino K., Takeuchi O., Kawai T. et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol1999; 162: 3749—3752.
Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med1999; 189: 1777—1782.
9.
Nagai Y., Akashi S., Nagafuku M. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution . Nat Immunol2002; 3: 667—672.
10.
Schromm AB, Lien E., Henneke P. et al. Molecular genetic analysis of an endotoxin non-responder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med2001; 194: 79—88.
11.
Miyake K., Ogata H., Nagai Y., Akashi S., Kimoto M.Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1. J Endotoxin Res2000; 6: 389—391.
12.
Akashi S., Saitoh S-i, Wakabayashi Y. et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4—MD-2: higher affinity than that with MD-2 or CD14. J Exp Med2003; 198: 1035—1042.
13.
Zhang H., Tay PN, Cao W., Li W., Lu J.Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling . FEBS Lett2002; 532: 171—176.
14.
Visintin A. , Latz E., Monks BG, Espevik T., Golenbock DTLysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction . J Biol Chem2003; 278: 48313—48320.
15.
Fukase K., Kirikae T., Kirikae F. et al. Synthesis of [3H]-labeled bioactive lipid A analogs and their use for detection of lipid A-binding proteins on murine macrophages. Bull Chem Soc Jpn2001; 74: 2189—2197.
16.
Akashi S., Nagai Y., Ogata H. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol2001; 13: 1595—1599.
17.
Saitoh S., Akashi S., Yamada T. et al. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization . Int Immunol2004; 16: 961—969.
